Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: A clinical endocrinological study of the ovarian response

Journal of Assisted Reproduction and Genetics

Volumn 19, Issue 7, 2002, Pages 313-318

  Geber, Selmo ^a,b   Sales, Liana ^a   Sampaio, Marcos A C ^a  

^a ORIGEN   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Downregulation; Functional cysts; GnRHa; IVF; Ovarian response

Indexed keywords

GONADORELIN DERIVATIVE; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; OVARY CYST; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; HYPOPHYSIS; MENSTRUAL CYCLE; METHODOLOGY; OVARY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; DOWN-REGULATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GOSERELIN; HUMAN; INJECTIONS, SUBCUTANEOUS; LEUPROLIDE; MENSTRUAL CYCLE; OVARY; OVULATION INDUCTION; PITUITARY GLAND; HUMANS;

EID: 0036021452     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016054424966     Document Type: Article

References (25)

1. A new systematic treatment for infertile women with abnormal hormone profiles
2. Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropins for in vitro fertilization
3. The effect of gonadotropin-releasing hormone agonist in the ovarian response and in vitro fertilization results in polycistic ovarian syndrome: A prospective study
4. The effect of gonadotrophin-releasing hormone (GNRH) agonist in the follicular phase on in vitro fertilization outcome in normo-ovulatory women
5. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropin in 408 first cycles of in vitro fertilization
6. The routine use of gonadotrophin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials
7. Programming in vitro fertilization for a 5- or 3-day week
8. Ovulation induction with human menopausal gonadotropin compared to urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function
9. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins
10. Induction of ovulation for in vitro fertilisation using buserelin and gonadotrophins
11. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonist in an in vitro fertilization program
12. Comparative trial of luteinizing hormone releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program
13. The long protocol of administration of gonadotrophin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization
14. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis
15. Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: A randomized comparative study
16. Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: A comparison between a single dose of Zoladex depot and multiple daily doses of suprefact
17. Blastomere development after embryo biopsy: A new model to predict embryo development and to select for transfer
18. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women
19. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction
20. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles
21. Comparison between depot leuprorelin and daily buserelin in IVF
22. The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist
23. Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization
24. Development of ovarian cysts during gonadotrophin-releasing hormone agonists (GnRHa) administration
25. Follicle cyst formation after administration of different gonadotrophin-releasing hormone analogues for assisted reproduction